Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial

Am J Respir Crit Care Med. 2026 May 1;212(5):989-1004. doi: 10.1093/ajrccm/aamag018.

Abstract

Rationale: Obesity hypoventilation syndrome (OHS) is treated with noninvasive ventilation (NIV) that is titrated during polysomnography. Auto-adjusted NIV could obviate the need for polysomnographic titration, thereby reducing costs and delays in care. However, non-inferiority long-term clinical trials comparing auto-adjusted NIV with manually-adjusted NIV are lacking.

Objectives: To determine the comparative effectiveness of automatic vs manual NIV modality in OHS.

Methods: In this multicenter, blinded, parallel group, non-inferiority and cost-effectiveness trial, we randomly assigned treatment-naïve ambulatory patients with OHS to auto-adjusted NIV (volume-targeted pressure support with auto-expiratory positive airway pressure) or manually-adjusted NIV (bilevel Positive Airway Pressure Spontaneous Timed mode (PAP ST).

Measurements: The primary outcome was change in daytime PaCO2 at 12 months, with the non-inferiority premise set at -2 mm Hg. Secondary outcomes included symptoms, quality of life, and healthcare resource utilization. Intention-to-treat and per-protocol analyses were performed.

Main results: 205 ambulatory patients with OHS were randomized, 107 to auto-adjusted NIV and 89 to manually-adjusted NIV. The mean [95% CI] improvement in PaCO2 was -9.2 [-9.7; -8.7] mm Hg in the auto-adjusted group and -8.7 [-9.1; -8.3] mm Hg in the manually-adjusted group, with mean adjusted difference of 0.15 mm Hg between groups ([low confidence limit -1.4]; non-inferiority P = .01). Cost-effectiveness was favorable to auto-adjusted group with a saving of 1528 € (95% CI, -2 370; -6 854) per patient. There were no significant differences in other secondary outcomes.

Conclusions: In ambulatory patients with OHS, auto-adjusted NIV had a non-inferior long-term effectiveness compared to manually-adjusted NIV while being more cost-effective. Auto-adjusted NIV may be preferred in clinical practice given its lower complexity and cost.

Clinicaltrial.gov identifier: NCT04327336.

Keywords: auto-adjusted noninvasive ventilation; noninvasive ventilation; obesity hypoventilation syndrome; sleep apnea.

MeSH terms

  • Aged
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Male
  • Middle Aged
  • Noninvasive Ventilation* / economics
  • Noninvasive Ventilation* / methods
  • Obesity Hypoventilation Syndrome* / therapy
  • Polysomnography
  • Quality of Life
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT04327336